Showing 941-950 of 1688 results for "".
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a
- Eucerin Introduces First Face Care Collection With Multi-Weight Hyaluronic Acid Technologyhttps://modernaesthetics.com/news/eucerin-introduces-first-face-care-collection-with-multi-weight-hyaluronic-acid-technology/2473544/Hitting shelves January 2024, Eucerin's Immersive Hydration Collection is a new entry into the face-care category with a unique, multi-weight hyaluronic acid formulation. A first to pioneer this technology across a full face care regimen* to intensively hydrate skin and visibly smoo
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o
- AestheticsWire Exclusive: Embracing Diversity in Aestheticshttps://modernaesthetics.com/news/embracing-diversity-in-aesthetics/2473528/There’s no such thing as a one-size-fits-all approach to rejuvenation as people across genders, ethnicities, and age groups often have different concerns and aesthetic goals. This is the main takeaway from a new study that sought to better understand facial and body aesthetic conc
- Revance Taps Erica Jordan as CCOhttps://modernaesthetics.com/news/revance-taps-erica-jordan-as-coo/2473522/Erica Jordan is now Revance Therapeutics, Inc.’s Chief Commercial Officer (CCO), Aesthetics. “Given the importance of the DAXXIFY launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having wo
- Modern Aesthetics® Named Exclusive Media Partner for Octane’s Aesthetics Tech Forum for Second Year in a Rowhttps://modernaesthetics.com/news/modern-aesthetics-named-exclusive-media-partner-for-octanes-aesthetics-tech-forum-for-second-year-in-a-row/2473520/Modern Aesthetics® magazine is the exclusive media partner for Octane’s Aesthetics Tech Forum for the second consecutive year. This year’s Forum will take place at the Balboa Bay Resort in Newport Beach, Calif. January 25-26, 2024.
- Natrelle Unveils New "For Every BODY" Campaignhttps://modernaesthetics.com/news/natrelle-unveils-new-for-every-body-campaign/2473519/Allergan Aesthetics’ is launching "For Every BODY," a new Natrelle campaign that showcases how the Natrelle breast implant portfolio can provide a customized look for every body. "Our mar
- BeautyHealth Launches New Hydrafacial School Partner Program for Student Estheticianshttps://modernaesthetics.com/news/beautyhealth-launches-new-hydrafacial-school-partner-program-for-student-estheticians/2473505/The Beauty Health Company is introducing the Hydrafacial School Partner Program to accredited esthetic schools across the U.S. Piloted first with select Paul Mitchell Schools and Aveda Institute locations, the Hydrafacial School Partner Program offers participating schools and the
- 10xBio Completes Enrollment of Phase 2b Trial of Novel Drug for Submental Body Contouringhttps://modernaesthetics.com/news/10xbio-completes-enrollment-of-phase-2b-trial-of-novel-drug-for-submental-body-contouring/2473477/10xBio completed enrollment in a repeat treatment study of its novel injectable drug for submental body contouring. The drug, 10